These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 10394795)

  • 21. Overlap analysis of the West of Scotland coronary prevention study (WOSCOPS).
    Lim PO; Yee KM
    Circulation; 1999 Aug; 100(6):686. PubMed ID: 10441109
    [No Abstract]   [Full Text] [Related]  

  • 22. Statin face-off. Surprises from the first head-to-head comparison.
    Gupta S
    Time; 2003 Nov; 162(21):83. PubMed ID: 14666603
    [No Abstract]   [Full Text] [Related]  

  • 23. Statins: true wonder drugs?
    Johns Hopkins Med Lett Health After 50; 2002 Jul; 14(5):1-2, 7. PubMed ID: 12154798
    [No Abstract]   [Full Text] [Related]  

  • 24. Statins as cardioprotective agents.
    Piskur JR; Stone NJ
    Am J Manag Care; 2002 Jun; 8(9 Suppl):25-9. PubMed ID: 12099325
    [No Abstract]   [Full Text] [Related]  

  • 25. [Cholesterol synthesis inhibitors: lowering of cholesterol for everybody?].
    Westendorp RG; Smelt AH
    Ned Tijdschr Geneeskd; 1996 Feb; 140(8):411-4. PubMed ID: 8720812
    [No Abstract]   [Full Text] [Related]  

  • 26. [Arteriosclerosis: how plaque heals].
    Neumaier J
    MMW Fortschr Med; 2002 Dec; 144(51-52):9. PubMed ID: 12596673
    [No Abstract]   [Full Text] [Related]  

  • 27. ["No infarct without elevated LDL cholesterol"!].
    Greten H
    MMW Fortschr Med; 2008 Nov; 150(48):119. PubMed ID: 19125517
    [No Abstract]   [Full Text] [Related]  

  • 28. HMG-CoA reductase inhibitors for treatment of hypercholesterolemia.
    Grundy SM
    N Engl J Med; 1988 Jul; 319(1):24-33. PubMed ID: 3288867
    [No Abstract]   [Full Text] [Related]  

  • 29. Statins: established indications and controversial subgroups.
    Jukema JW; Bergheanu SC
    Heart; 2008 Dec; 94(12):1656-62. PubMed ID: 19011141
    [No Abstract]   [Full Text] [Related]  

  • 30. The smart take on statins.
    Kotz D
    US News World Rep; 2008 Feb; 144(5):41-5. PubMed ID: 18361207
    [No Abstract]   [Full Text] [Related]  

  • 31. [Inhibitors of HMG CoA reductase: new modes of action, new indications?].
    Essig M; Vrtovsnik F; Friedlander G
    Therapie; 2000; 55(1):43-9. PubMed ID: 10860000
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stricter cholesterol guidelines broaden indications for the 'statin' drugs.
    Capriotti T
    Medsurg Nurs; 2003 Feb; 12(1):51-7. PubMed ID: 12619600
    [No Abstract]   [Full Text] [Related]  

  • 33. [Critical evaluation of indications for lipid reduction. Cholesterol value updated--risk counts (interview by Dr. Kirsten Westphal)].
    Motz W
    MMW Fortschr Med; 2003 Oct; 145(41):48. PubMed ID: 14655487
    [No Abstract]   [Full Text] [Related]  

  • 34. Communicating risk reductions. One example is not enough.
    Galton DJ; Seed M
    BMJ; 1999 Feb; 318(7183):602-3; author reply 603-4. PubMed ID: 10189215
    [No Abstract]   [Full Text] [Related]  

  • 35. Statins "R" us. Pediatricians call for cholesterol-lowering drugs for some kids. Is this a quick fix for obesity's ills?
    Park A
    Time; 2008 Jul; 172(3):58. PubMed ID: 18655389
    [No Abstract]   [Full Text] [Related]  

  • 36. By the way, doctor. I have high cholesterol, and have been taking Mevacor (lovastatin) for two years. Recently, I was switched to Pravachol (pravastatin) because my insurance company would no longer pay for Mevacor. Is it as good?
    Nicholson CR
    Harv Womens Health Watch; 1999 Jun; 6(10):8. PubMed ID: 10233830
    [No Abstract]   [Full Text] [Related]  

  • 37. Perspectives in cholesterol-lowering therapy: the role of ezetimibe, a new selective inhibitor of intestinal cholesterol absorption.
    Bruckert E; Giral P; Tellier P
    Circulation; 2003 Jul; 107(25):3124-8. PubMed ID: 12835406
    [No Abstract]   [Full Text] [Related]  

  • 38. Statins.
    McLoughlin C
    Prof Nurse; 2004 Jul; 19(11):51-2. PubMed ID: 15317342
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hypercholesterolemia. Is lipid-lowering worthwhile for older patients?
    Deedwania PC
    Geriatrics; 2000 May; 55(5):22-8. PubMed ID: 10826262
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effect of cholesterol reducing therapy with 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor on secondary prevention after myocardial infarction in Japanese patients].
    Tachibana E; Watanabe I; Nagao K; Kanmatsuse K
    J Cardiol; 2000 Apr; 35(4):277-85. PubMed ID: 10791271
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.